The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
- PMID: 28759649
- PMCID: PMC5552337
- DOI: 10.1371/journal.ppat.1006546
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
Abstract
Infection by enveloped coronaviruses (CoVs) initiates with viral spike (S) proteins binding to cellular receptors, and is followed by proteolytic cleavage of receptor-bound S proteins, which prompts S protein-mediated virus-cell membrane fusion. Infection therefore requires close proximity of receptors and proteases. We considered whether tetraspanins, scaffolding proteins known to facilitate CoV infections, hold receptors and proteases together on cell membranes. Using knockout cell lines, we found that the tetraspanin CD9, but not the tetraspanin CD81, formed cell-surface complexes of dipeptidyl peptidase 4 (DPP4), the MERS-CoV receptor, and the type II transmembrane serine protease (TTSP) member TMPRSS2, a CoV-activating protease. This CD9-facilitated condensation of receptors and proteases allowed MERS-CoV pseudoviruses to enter cells rapidly and efficiently. Without CD9, MERS-CoV viruses were not activated by TTSPs, and they trafficked into endosomes to be cleaved much later and less efficiently by cathepsins. Thus, we identified DPP4:CD9:TTSP as the protein complexes necessary for early, efficient MERS-CoV entry. To evaluate the importance of these complexes in an in vivo CoV infection model, we used recombinant Adenovirus 5 (rAd5) vectors to express human DPP4 in mouse lungs, thereby sensitizing the animals to MERS-CoV infection. When the rAd5-hDPP4 vectors co-expressed small RNAs silencing Cd9 or Tmprss2, the animals were significantly less susceptible, indicating that CD9 and TMPRSS2 facilitated robust in vivo MERS-CoV infection of mouse lungs. Furthermore, the S proteins of virulent mouse-adapted MERS-CoVs acquired a CD9-dependent cell entry character, suggesting that CD9 is a selective agent in the evolution of CoV virulence.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5552337/bin/ppat.1006546.g006.gif)
Similar articles
-
Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.J Virol. 2017 Sep 12;91(19):e00534-17. doi: 10.1128/JVI.00534-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28747502 Free PMC article.
-
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3119-E3128. doi: 10.1073/pnas.1619109114. Epub 2017 Mar 27. Proc Natl Acad Sci U S A. 2017. PMID: 28348219 Free PMC article.
-
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550352 Free PMC article.
-
[Development of peptidic MERS-CoV entry inhibitors].Yao Xue Xue Bao. 2015 Dec;50(12):1513-9. Yao Xue Xue Bao. 2015. PMID: 27169270 Review. Chinese.
-
Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives.Annu Rev Virol. 2015 Nov;2(1):95-117. doi: 10.1146/annurev-virology-100114-055029. Epub 2015 Aug 7. Annu Rev Virol. 2015. PMID: 26958908 Review.
Cited by
-
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans.bioRxiv [Preprint]. 2024 Apr 2:2024.03.31.586409. doi: 10.1101/2024.03.31.586409. bioRxiv. 2024. PMID: 38617298 Free PMC article. Preprint.
-
Phospho-eIF4E stimulation regulates coronavirus entry by selective expression of cell membrane-residential factors.J Virol. 2024 Feb 20;98(2):e0194823. doi: 10.1128/jvi.01948-23. Epub 2024 Feb 1. J Virol. 2024. PMID: 38299843
-
Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects.Int J Mol Sci. 2024 Jan 4;25(1):640. doi: 10.3390/ijms25010640. Int J Mol Sci. 2024. PMID: 38203811 Free PMC article. Review.
-
Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics.Viruses. 2023 Oct 6;15(10):2056. doi: 10.3390/v15102056. Viruses. 2023. PMID: 37896834 Free PMC article.
-
Dynamic association of the intramembrane proteases SPPL2a/b and their substrates with tetraspanin-enriched microdomains.iScience. 2023 Sep 4;26(10):107819. doi: 10.1016/j.isci.2023.107819. eCollection 2023 Oct 20. iScience. 2023. PMID: 37736044 Free PMC article.
References
-
- Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of virology. 2010;84(11):5605–14. doi: 10.1128/JVI.00140-10 ; PubMed Central PMCID: PMC2876594. - DOI - PMC - PubMed
-
- Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JAT. Retroviral Entry Mediated by Receptor Priming and Low pH Triggering of an Envelope Glycoprotein. Cell. 2000;103(4):679–89. doi: 10.1016/S0092-8674(00)00170-7 - DOI - PubMed
-
- Matsuyama S, Taguchi F. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. Journal of virology. 2009;83(21):11133–41. Epub 2009/08/27. doi: 10.1128/JVI.00959-09 ; PubMed Central PMCID: PMCPMC2772765. - DOI - PMC - PubMed
-
- Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, et al. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. Journal of virology. 1991;65(12):6881–91. Epub 1991/12/01. ; PubMed Central PMCID: PMCPmc250787. - PMC - PubMed
-
- Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–4. Epub 2003/12/04. doi: 10.1038/nature02145 . - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous